Cargando...
Beyond Sipuleucel-T: Immune Approaches to Treating Prostate Cancer
At present, sipuleucel-T represents the only approved immunotherapy for prostate cancer. Sipuleucel-T is an autologous cellular therapy, which primes autologous antigen-presenting cells against the prostatic acid phosphatase (PAP) antigen. For patients with metastatic castrate-resistant prostate can...
Guardado en:
| Publicado en: | Curr Treat Options Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4523381/ https://ncbi.nlm.nih.gov/pubmed/24402184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-013-0267-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|